CALC
Price
$3.08
Change
-$0.09 (-2.84%)
Updated
Sep 5 closing price
Capitalization
43.03M
VTYX
Price
$2.52
Change
-$0.08 (-3.08%)
Updated
Sep 5 closing price
Capitalization
185.4M
67 days until earnings call
Interact to see
Advertisement

CALC vs VTYX

Header iconCALC vs VTYX Comparison
Open Charts CALC vs VTYXBanner chart's image
CalciMedica
Price$3.08
Change-$0.09 (-2.84%)
Volume$33.05K
Capitalization43.03M
Ventyx Biosciences
Price$2.52
Change-$0.08 (-3.08%)
Volume$430.46K
Capitalization185.4M
CALC vs VTYX Comparison Chart in %
Loading...
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CALC vs. VTYX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALC is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CALC: $3.08 vs. VTYX: $2.52)
Brand notoriety: CALC and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CALC: 38% vs. VTYX: 49%
Market capitalization -- CALC: $43.03M vs. VTYX: $185.4M
CALC [@Biotechnology] is valued at $43.03M. VTYX’s [@Biotechnology] market capitalization is $185.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALC’s FA Score shows that 1 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • CALC’s FA Score: 1 green, 4 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, CALC is a better buy in the long-term than VTYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALC’s TA Score shows that 4 TA indicator(s) are bullish while VTYX’s TA Score has 2 bullish TA indicator(s).

  • CALC’s TA Score: 4 bullish, 3 bearish.
  • VTYX’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CALC is a better buy in the short-term than VTYX.

Price Growth

CALC (@Biotechnology) experienced а +14.07% price change this week, while VTYX (@Biotechnology) price change was +5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

VTYX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTYX($185M) has a higher market cap than CALC($43M). VTYX YTD gains are higher at: 15.068 vs. CALC (-12.994). CALC has higher annual earnings (EBITDA): -30.55M vs. VTYX (-129.1M). VTYX has more cash in the bank: 209M vs. CALC (18M). CALC has less debt than VTYX: CALC (8.5M) vs VTYX (10.3M). CALC (0) and VTYX (0) have equivalent revenues.
CALCVTYXCALC / VTYX
Capitalization43M185M23%
EBITDA-30.55M-129.1M24%
Gain YTD-12.99415.068-86%
P/E Ratio0.30N/A-
Revenue00-
Total Cash18M209M9%
Total Debt8.5M10.3M83%
TECHNICAL ANALYSIS
Technical Analysis
CALCVTYX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SELX1.120.04
+3.70%
Semilux International Ltd
MXL15.630.08
+0.51%
MaxLinear
PM161.550.40
+0.25%
Philip Morris International
IDA125.360.19
+0.15%
IDACORP
LFMD6.06-0.22
-3.50%
LifeMD

CALC and

Correlation & Price change

A.I.dvisor tells us that CALC and OBIO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CALC and OBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
-2.84%
OBIO - CALC
33%
Poorly correlated
+0.36%
ALDX - CALC
26%
Poorly correlated
+0.54%
VTYX - CALC
26%
Poorly correlated
-3.08%
TRAW - CALC
26%
Poorly correlated
+7.51%
STRO - CALC
25%
Poorly correlated
+3.92%
More